As our Numerof 2022 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about continuing to adapt to pressures on price and demands for value, while dealing with the aftereffects of the pandemic.
As our Numerof 2022 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value while dealing with the aftereffects of the pandemic.
Among the many trends accelerated by the pandemic was the overhaul of pharma’s commercial model. It was tacitly understood to be ripe for change – the cost was increasingly conspicuous, and the results increasingly suspect. The prior model had grown out of step with field realities. Employed physicians had less…
